Human CEA(Carcinoembryonic Antigen) ELISA Kit
中文名称：人癌胚抗原(CEA)酶联免疫吸附测定试剂盒
Price:
- 反应性： Human
- 检测范围： 0.16-10 ng/mL
- 灵敏度： 0.1 ng/mL
| 产品应用 | ELISA |
| 检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人CEA抗体包被于酶标板上，实验时样品（或标准品）中的人CEA会与包被抗体结合。后依次加入生物素化的抗人CEA抗体和辣根过氧化物酶标记的亲和素，抗人CEA抗体与结合在包被抗体上的人CEA结合，生物素与亲和素特异性结合而形成免疫复合物，游离的成分被洗去。加入显色底物(TMB)，TMB在辣根过氧化物酶的催化下呈现蓝色，加终止液后变成黄色。用酶标仪在450 nm波长处测OD值，CEA浓度与OD450值之间呈正比，通过绘制标准曲线计算出样品中CEA的浓度。 |
| 反应类型 | Sandwich-ELISA |
| 规格 |
96 T
/ 48 T
/ 96 T × 5
|
| 反应时间 | 3 h 30 min |
| 反应性 | Human |
| 检测方法 | 比色法;ELISA;夹心法 |
| 检测范围 | 0.16-10 ng/mL |
| 灵敏度 | 0.1 ng/mL |
| 样本体积 | 100 μL |
| 样本类型 | 血清、血浆或其他生物体液 |
| 特异性 | 可检测样本中的人CEA，且与其它类似物无明显交叉反应 |
| 精密度 | 板内，板间变异系数均<10% |
| 回收率 | 80%-120% |
| 储存条件 | 2-8℃ |
| 有效期 | 12个月 |
| 数据处理 |
-
The CRISPR/Cas system-mediated function of Hg2+ on urease activity for colorimetric detection of the tumor biomarker in clinical samples
IF: 4.900Journal： MICROCHEMICAL JOURNAL (2024)Reactivity：HumanSample Type：serum -
Fluorescence-infrared absorption dual-mode nanoprobes based on carbon dots@SiO2 nanorods for ultrasensitive and reliable detection of carcinoembryonic antigen
IF: 6.057 -
Development of a serum miRNA panel for detection of early stage non-small cell lung cancer
IF: 9.412Journal： PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)PMID：32943537Reactivity：HumanSample Type：Serum -
In situ amplified QCM immunoassay for carcinoembryonic antigen with colorectal cancer using horseradish peroxidase nanospheres and enzymatic biocatalytic precipitation
IF: 3.978 -
Hsa_circ_0124055 and hsa_circ_0101622 regulate proliferation and apoptosis in thyroid cancer and serve as prognostic and diagnostic indicators.
IF: 3.024Journal： European Review for Medical and Pharmacological Sciences (2020)PMID：32373972Reactivity：HumanSample Type：Serum,Tissue homogenate -
A potentiometric aptasensor for carcinoembryonic antigen (CEA) on graphene oxide nanosheets using catalytic recycling of DNase I with signal amplification
IF: 2.073 -
Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis
IF: 1.736
实验操作视频
